Published in Haematologica on November 04, 2011
Cancer in Inherited Bone Marrow Failure Syndromes | NCT00027274
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
The telomere syndromes. Nat Rev Genet (2012) 4.01
Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 3.39
Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev (2013) 2.14
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Telomerase is required for zebrafish lifespan. PLoS Genet (2013) 1.59
Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. Am J Hum Genet (2012) 1.54
Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica (2012) 1.45
Assessment of Telomere Length in Archived Formalin-Fixed, Paraffinized Human Tissue Is Confounded by Chronological Age and Storage Duration. PLoS One (2016) 1.38
Bone marrow failure and the telomeropathies. Blood (2014) 1.23
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev (2014) 1.07
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet (2013) 1.05
Understanding telomere diseases through analysis of patient-derived iPS cells. Curr Opin Genet Dev (2013) 1.03
Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder. Br J Haematol (2015) 1.01
A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia. Chest (2014) 1.01
Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia. Br J Haematol (2012) 1.01
Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita. Blood (2012) 0.99
Dubowitz syndrome is a complex comprised of multiple, genetically distinct and phenotypically overlapping disorders. PLoS One (2014) 0.95
The molecular genetics of the telomere biology disorders. RNA Biol (2015) 0.91
Recognizing familial myeloid leukemia in adults. Ther Adv Hematol (2013) 0.90
Response to androgen therapy in patients with dyskeratosis congenita. Br J Haematol (2014) 0.89
Leukocyte telomere length variation due to DNA extraction method. BMC Res Notes (2014) 0.87
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clin Lymphoma Myeloma Leuk (2016) 0.86
Telomere length in inherited bone marrow failure syndromes. Haematologica (2014) 0.85
Age-related declines and disease-associated variation in immune cell telomere length in a wild mammal. PLoS One (2014) 0.84
Immune status of patients with inherited bone marrow failure syndromes. Am J Hematol (2015) 0.81
Decreasing initial telomere length in humans intergenerationally understates age-associated telomere shortening. Aging Cell (2015) 0.80
Cold-inducible RNA-binding protein CIRP/hnRNP A18 regulates telomerase activity in a temperature-dependent manner. Nucleic Acids Res (2015) 0.78
Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders. Blood (2014) 0.78
Telomere-driven diseases and telomere-targeting therapies. J Cell Biol (2017) 0.77
Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population. Korean J Intern Med (2015) 0.77
Short Telomeres in Key Tissues Initiate Local and Systemic Aging in Zebrafish. PLoS Genet (2016) 0.75
Characterization of population-based variation and putative functional elements for the multiple-cancer susceptibility loci at 5p15.33. F1000Res (2014) 0.75
Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up. Pediatr Neurol (2015) 0.75
The shelterin complex and hematopoiesis. J Clin Invest (2016) 0.75
DNA methylation in PRDM8 is indicative for dyskeratosis congenita. Oncotarget (2016) 0.75
The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita. Mol Genet Genomic Med (2016) 0.75
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant (2017) 0.75
Clinical and Molecular Heterogeneity of RTEL1 Deficiency. Front Immunol (2017) 0.75
Progressive reticulate skin pigmentation and anonychia in a patient with bone marrow failure. J Am Acad Dermatol (2017) 0.75
Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement. PLoS One (2017) 0.75
The Role of Genetic Testing in Hereditary Poikiloderma: A Case Report. Glob Pediatr Health (2017) 0.75
Telomeres and aging. Physiol Rev (2008) 4.79
How telomeres solve the end-protection problem. Science (2009) 4.54
Cancer in dyskeratosis congenita. Blood (2009) 4.28
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc (2006) 4.00
Dyskeratosis congenita in all its forms. Br J Haematol (2000) 3.89
Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood (2005) 3.30
Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev (2010) 3.24
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02
Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. Am J Epidemiol (2008) 2.86
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet (2003) 2.76
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69
Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2. Clin Genet (2011) 1.08
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med (2004) 12.20
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med (2007) 8.23
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest (2008) 6.15
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 6.00
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol (2003) 5.38
Telomeres and aging. Physiol Rev (2008) 4.79
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. J Clin Oncol (2013) 4.50
Pathway analysis by adaptive combination of P-values. Genet Epidemiol (2009) 4.48
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Cancer in dyskeratosis congenita. Blood (2009) 4.28
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc (2006) 4.00
Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA. Nat Genet (2002) 3.50
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell (2004) 2.91
Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA (2010) 2.78
Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet (2003) 2.76
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood (2003) 2.73
PGA: power calculator for case-control genetic association analyses. BMC Genet (2008) 2.71
Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64
Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst (2007) 2.63
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 2.44
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst (2009) 2.33
Competing risks analysis of correlated failure time data. Biometrics (2007) 2.31
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol (2006) 2.21
Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol (2009) 2.20
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol (2005) 2.11
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet (2006) 2.10
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst (2003) 2.07
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature (2011) 2.03
The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A (2005) 2.01
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst (2011) 1.97
Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol (2007) 1.97
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med (2004) 1.92
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer (2009) 1.91
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood (2014) 1.88
DNA template strand sequencing of single-cells maps genomic rearrangements at high resolution. Nat Methods (2012) 1.85
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82
Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS (2003) 1.81
Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res (2011) 1.79
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet (2011) 1.73
End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood (2002) 1.73
Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer (2009) 1.71
Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood (2012) 1.69
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol (2011) 1.67
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood (2011) 1.65
Cancer in Fanconi anemia. Blood (2003) 1.63
Synchrony of telomere length among hematopoietic cells. Exp Hematol (2010) 1.63
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) (2010) 1.62
Mutations in the SBDS gene in acquired aplastic anemia. Blood (2007) 1.62
Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol (2002) 1.59
Telomerase levels control the lifespan of human T lymphocytes. Blood (2003) 1.59
Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res Treat (2006) 1.58
A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57
Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood (2006) 1.57
Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet (2012) 1.57
RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol (2006) 1.54
Detection of G-quadruplex DNA in mammalian cells. Nucleic Acids Res (2013) 1.53
Identification of sister chromatids by DNA template strand sequences. Nature (2009) 1.53
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res (2010) 1.51
Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum Mol Genet (2003) 1.48
Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.48
Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology (2009) 1.47
All in the family: disclosure of "unwanted" information to an adolescent to benefit a relative. Am J Med Genet A (2008) 1.44
Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry (2002) 1.43
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res (2011) 1.37
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood (2005) 1.37